A L Tsai1, H Vijjeswarapu, K K Wu
1Department of Internal Medicine, University of Texas Health Science Center, Houston 77225.
The 16(S) iloprost isomer is significantly more potent than the 16(R) isomer in inhibiting platelet aggregation and exhibits distinct receptor binding characteristics. This difference is attributed to the molecule's orientation within the prostacyclin receptor channel.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: